Deep Bio today announced the publication of a study evaluating the performance of its AI algorithm for breast cancer analysis to accurately differentiate between invasive ductal carcinoma (IDC) lesions from non-invasive ductal carcinoma in situ (DCIS) lesions in biopsies taken after breast cancer surgery.
1. The hazard ratio for recurrence or death comparing sentinel node biopsy only to completion axillary lymph node dissection was non-significant (0.89) and below the noninferiority margin. 2. The overall survival rates at 5 years were similar between both groups, 92.9% vs 92%. Evidence Rating Level: 1 (Excellent) Study Rundown: Previous studies have challenged the necessity
/PRNewswire/ SkylineDx an innovative diagnostics company focused on research & development of molecular diagnostics for oncology and inflammatory diseases,.
SkylineDx: Real World Prospective Study shows clinical implementation of Merlin Assay (CP-GEP) in melanoma care finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Skin cancer is the most common cancer in the world. HELLO! spoke to Dr. Peter Dziewulski to understand the disease in more detail, including signs, types and treatment options